Bodman Uzy MD - Hollywood, Florida 33023

Bodman Uzy MD is categorized under Doctors in Hollywood, FL .

Business Name: Bodman Uzy MD
Contact Person: Uzy Bodman
Address: 6161 Miramar Parkway, Hollywood, Florida 33023
Phone Number: (954) 986-0030
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Kevin Paul Bethel M D C M F A A R M - Hollywood, FL 33023
Martinez Munev Maria P MD - Hollywood, FL 33023
Ahmed Sultan S MD - Hollywood, FL 33023
Cohen Clarence L MD - Hollywood, FL 33023
Wirth Cynthia D MD - Hollywood, FL 33023
Bamberg Norman B MD - Hollywood, FL 33023
Phoenix Clinic Inc - Hollywood, FL 33023
Briones Luis R MD - Hollywood, FL 33023
Fernandez Hugo S MD - Hollywood, FL 33023
Wasserman Norman MD - Hollywood, FL 33023
Garcia Jose E MD - Hollywood, FL 33023
Gibaja-Aragon David MD - Hollywood, FL 33023
M D Flowers - Hollywood, FL 33023
Mionbet Stefano MD - Hollywood, FL 33023
Mendez-Irizarr Lesbia MD - Hollywood, FL 33023
Sunrise Pulmonary - Hollywood, FL 33023
Miramar Medical Center For Chiro - Hollywood, FL 33023
A Womens Place - Hollywood, FL 33023
Katz Ira MD - Hollywood, FL 33023
Memorial Hospital Primary Care - Hollywood, FL 33023

The company Bodman Uzy MD provides B2C services in the form of Doctors from its single location in Florida. 1 to 4 employees work for Bodman Uzy MD, and the business now earns $500.000 to $999.999 per annum.

Bodman Uzy MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Bodman Uzy MD, please call Uzy Bodman with the phone number (954) 986-0030 or visit its single location at 6161 Miramar Parkway in Hollywood, Florida 33023.

The location of the single location can also be found using the coordinates 25.984481,-80.210348. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.